FDA Approves New Drug for Schizophrenia, Bipolar Disorder

FRIDAY, Sept. 18, 2015 — A new antipsychotic drug to treat schizophrenia and bipolar disorder in adults has been approved by the U.S. Food and Drug Administration.
The drug, Vraylar (cariprazine), is a capsule taken once a day.
Source: Topamax